Division of BioTherapeutics
Our research is aimed at a smoother and speedier transition from preclinical research to pharmacological interventions, and the delivery of drugs in the human body by use of small molecules and biologics.
Welcome to the division of BioTherapeutics. Our work aims at the innovative biopharmaceutical concepts to intervene in auto-immune-like disorders, using biologics such as vaccines and therapeutic proteins.
We strive for an integration of our experimental in-vitro and in-vivo data, in order to develop quantitative systems biology models of health and disease states, thus enabling us to better predict efficacy and drug safety. A special aim lies in finding new targets in immune based diseases such as atherosclerosis.